Vote for Battelle's revolutionizing gene therapy delivery entry in this SAE Media Group TechBriefs Create the Future Design Contest https://okt.to/p4gUAs Deadline July 8. Battelle entry is here https://okt.to/T2xK1F
Battelle’s Post
More Relevant Posts
-
How can iPSC-based approaches accelerate AAV #genetherapy development? Gain a deeper understanding of our #drugdiscovery platforms and how we apply iPSCs to gene therapy development in this #webinar. Watch the replay to learn more: https://lnkd.in/e9jzsEjU
To view or add a comment, sign in
-
Check out this article I wrote for TESS Research Foundation's #ScienceSimplified blog on gene therapy clinical trials: https://bit.ly/3xiF152 In considering gene therapy, whether through a clinical trial or after it is approved, it is key to define your desired outcomes, what risks are acceptable to you, and if gene therapy is the right choice for you. #genetherapy #blog #sciencecommunication #scicomm #clinicaltrial #decisionmaking
Our latest #ScienceSimplified highlights the differences between a gene therapy clinical trial and a cure. 🧬💜 Read the latest article authored by Zollie Yavarow, PhD, MA here: https://bit.ly/3xiF152 #SLC13A5Epilepsy #TESSResearch
To view or add a comment, sign in
-
-
Absolutely fascinated by the advances in gene therapy. With time we'll see this treatment become standard practice. This is sure to massively increase our life expectancy. #genetherapy #genetictesting #exometesting https://lnkd.in/dRQfuFP6
To view or add a comment, sign in
-
Harness the power of innovation in gene therapy. Advanced technologies like SEC-MALS and CDMS are revolutionizing analytical development and quality control testing. Save your spot for our upcoming webinar on May 30th and stay ahead of the curve. #AAV #genetherapy
To view or add a comment, sign in
-
-
The blood-brain barrier (BBB) is an obstacle to gene therapy delivery, as methods that work for other organs may not necessarily be able to cross the BBB. In this webinar, Douglas Marchuk and Viviana Gradinaru explain how overcoming the BBB allows them to investigate new approaches for combatting neurological disease. Register now: https://ow.ly/pIaJ50Swh6n
To view or add a comment, sign in
-
-
We outline strategies for reducing the volumes required for stability studies with the goal of conserving the product for patients while remaining compliant and delivering data on critical quality attributes across the shelf life of gene therapy products. You can download the PDF for FREE here 👉🏻 https://okt.to/NzahcR #biophorum #biopharma #genetherapy #celltherapy
Minimizing the impact of stability testing on gene therapy batch yield
To view or add a comment, sign in
-
Intravenous administration typically involves shorter treatment durations and less invasive procedures than alternative routes. For comprehensive insights into the U.S. Gene Therapy Market, click @ https://lnkd.in/d8EAq-ji. #gvr #healthcare #HealthcareForAll #gene #Medical #clinicaltrials #clinicalresearch
To view or add a comment, sign in
-
-
Everything you need to know about GENE THERAPY for hemophilia A and B. First illustrated review describing basic principles, current evidence &clinical implementation by Cihan Ay et al published in @haemophilia journal It has been a wonderful experience curating the illustrations for the team. Art4Science (https://lnkd.in/e5eiWVtF) https://lnkd.in/eU2jv33N #genetherapy #haematology #hemophilia
Cihan Ay (@Cihan_Ay_MD) on X
twitter.com
To view or add a comment, sign in
-
When developing a gene therapy process, it can be hard to know where to start. Have no fear, our new filter selection guide is here to help. Download your free copy - https://cytiva.link/4snhx #mRNA #filtration
To view or add a comment, sign in
-
-
When developing a gene therapy process, it can be hard to know where to start. Have no fear, our new filter selection guide is here to help. Download your free copy - https://cytiva.link/4snhx #mRNA #filtration
To view or add a comment, sign in
-